Biogen Insufficiency Explained; Alendronate in Netherlands; Behaviour Relevant to Injunction; Perindopril Evergreening Criticised; ‘Negative Term’ SPCs'; New Dosage Regimes
Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector · 2008
DOI: 10.1057/jgm.2008.16 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector, 2008. Verfasst von Michael Burdon und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Burdon, M., Singleton, R., Katzka, C., MacIntyre, J., & Kusumakar, S. (2008). Biogen Insufficiency Explained; Alendronate in Netherlands; Behaviour Relevant to Injunction; Perindopril Evergreening Criticised; ‘Negative Term’ SPCs'; New Dosage Regimes. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. https://doi.org/10.1057/jgm.2008.16
Vancouver
Burdon M, Singleton R, Katzka C, MacIntyre J, Kusumakar S. Biogen Insufficiency Explained; Alendronate in Netherlands; Behaviour Relevant to Injunction; Perindopril Evergreening Criticised; ‘Negative Term’ SPCs'; New Dosage Regimes. Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector. 2008. doi:10.1057/jgm.2008.16
BibTeX
@article{Burdon2008,
author = {Burdon, Michael and Singleton, Rebecca and Katzka, Catherine and MacIntyre, Jade and Kusumakar, Siddharth},
title = {Biogen Insufficiency Explained; Alendronate in Netherlands; Behaviour Relevant to Injunction; Perindopril Evergreening Criticised; ‘Negative Term’ SPCs'; New Dosage Regimes},
journal = {Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector},
year = {2008},
doi = {10.1057/jgm.2008.16}
}
EUVIMED